Recorded webinars wtih Professor Richard Costello and Professor David Price
Professor David Price: Current unmet needs & goals of inhalation therapies
Professor Richard Costello: How digital innovations could help HCPs achieve inhalation treatment goals
Reporting of side effects
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance, website www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing [email protected] or by calling (01) 2080 612.